Skip to main content

Home/ medindia/ Group items tagged exercise

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Alex Parker

GlaxoSmithKline's Tanzeum gets FDA approval for type 2 diabetes treatment - 1 views

drugdelivery.pharmaceutical-business-review.com/...betes-treatment-160414-4215125

health news medical pharma

shared by Alex Parker on 16 Apr 14 - No Cached
  • Alex Parker on 16 Apr 14
     
    GSK has received approval from FDA for its Tanzeum subcutaneous injection to improve glycemic control, along with diet and exercise, in adult patients with type 2 diabetes.
med india

Physical Activity Reduces Mortality in People With Metabolic Syndrome | MedIndia - 0 views

www.medindia.net/...Metabolic-Syndrome-91796-1.htm

physical activity and mortality heart disease stroke diabetes diet exercise metabolic syndrome death regular weight loss. daily health news for the day dental pharma medical breakthroughs topic

shared by med india on 11 Oct 11 - No Cached
  • med india on 11 Oct 11
     
    Metabolic syndrome is a term used for a group of risk factors that, if present together in a person, increase the risk of heart disease, stroke and diabetes. It is also known as Syndrome X or Insulin Resistance Syndrome.
med india

Health & Wellness Infographics | Medindia - 0 views

www.medindia.net/...fographics-health-wellness.asp

and wellness Infographics Medical health information care condition family exercise fitness issues

shared by med india on 22 Oct 11 - No Cached
  • med india on 22 Oct 11
     
    Medindia provides an Popular Infographics on different aspects of health and wellness that can help make our community a healthier place to live.
Alex Parker

GlaxoSmithKline's once-weekly diabetes drug Eperzan gets marketing approval in Europe - 1 views

drugdelivery.pharmaceutical-business-review.com/...roval-in-europe-270314-4204343

health news medical pharma

shared by Alex Parker on 27 Mar 14 - No Cached
  • Alex Parker on 27 Mar 14
     
    PBR Staff Writer Published 27 March 2014 The European Commission (EC) has granted marketing authorization for GlaxoSmithKline's (GSK's) once-weekly diabetes treatment, Eperzan (albiglutide). The drug is indicated for the treatment of type 2 diabetes mellitus in adults, to improve glucose control as monotherapy, when diet and exercise alone do not provide adequate glycaemic control in patients for whom the use of metformin is considered inappropriate due to contraindications or intolerance.
1 - 4 of 4
Showing 20▼ items per page